This content is machine translated 25th United European Gastroenterology Week (UEGweek), Barcelona New ways to treat inflammatory bowel disease Numerous new drug classes are currently in development, and the goal of individualized treatment of inflammatory bowel diseases with few side effects is approaching. Here, biomarkers play an important role…
View Post 7 min This content is machine translated Cystic fibrosis A “childhood disease” has grown up Improvements in disease management increase the quality of life and life expectancy of patients with cystic fibrosis. Newborn screening, introduced in 2011, enables early diagnosis. However, the disease should also…
View Post 8 min This content is machine translated Hepatitis C Light at the end of the tunnel The introduction of interferon-free combination therapies with “direct acting antivirals” (DAA) was a breakthrough. Medically, therapy with current drugs can be recommended to all patients with active HCV infection. As…
View Post 1 min This content is machine translated Video advanced training St. Claraspital Gastroforum Systemic therapeutic options for hepatocelullary carcinoma. Dr. Melanie Löffler-Baumann, Senior Physician St. Claraspital, Basel, will give an overview of the current status in the field of system therapies.
View Post 4 min This content is machine translated Annual Meeting DGHO, OeGHO, SGMO and SGH+SSH in Stuttgart, Germany Update hepatocellular carcinoma – news from the system therapy In hepatocellular carcinoma, an increase in incidence has been observed in industrialized countries. HCC patients have at least two diseases, namely carcinoma as well as severe liver disease. The interaction…
View Post 8 min This content is machine translated ASCO 2017 in Chicago Groundbreaking on tumors of the prostate and gallbladder There was big news at the 2017 ASCO Congress. First, abiraterone is pushing into the first-line setting in metastatic prostate cancer. On the other hand, there is a new standard…
View Post 8 min This content is machine translated Chronic inflammatory bowel disease Innovative therapeutic approaches for IBD Last year, the integrin inhibitor or leukocyte migration inhibitor vedolizumab was approved in Switzerland for Crohn’s disease and ulcerative colitis. In addition, biosimilars for infliximab have entered the market. Furthermore,…
View Post 8 min This content is machine translated Therapy for gastrointestinal stromal tumors Surgical and oncological aspects Before initiating therapy, GIST patients should be discussed at an interdisciplinary tumor board. For intermediate to high risk of relapse, adjuvant imatinib therapy should be considered after resection. Patients with…
View Post 5 min This content is machine translated Colorectal cancer Why are more and more younger patients becoming ill? There is a significant increase in the incidence of colorectal cancer in the age group below 55 years. In older individuals, diagnoses have been steadily declining for years. Screening recommendations…
View Post 4 min This content is machine translated 2nd Spring Congress of the SGAIM Viral hepatitides – how and whom to test? Hepatitis C is the “favorite child” of current medical ethics discussions. However, the new, expensive HCV drugs should not cloud the view of the overall diagnostic and therapeutic situation of…
View Post 5 min This content is machine translated Liver disease Possibilities of treatment with milk thistle Pharmacological and clinical studies support the efficacy of milk thistle extracts and silymarin – an overview of diseases and efficacy studies.
